• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
QIN Xingyu, FENG Rui, DI Bin. Synthesis of hydralazine-N-lactose and its metabolites in vitro[J]. Journal of China Pharmaceutical University, 2017, 48(6): 687-695. DOI: 10.11665/j.issn.1000-5048.20170609
Citation: QIN Xingyu, FENG Rui, DI Bin. Synthesis of hydralazine-N-lactose and its metabolites in vitro[J]. Journal of China Pharmaceutical University, 2017, 48(6): 687-695. DOI: 10.11665/j.issn.1000-5048.20170609

Synthesis of hydralazine-N-lactose and its metabolites in vitro

More Information
  • Hydralazine-N-lactose is a main impurity in hydralazine tablets. Hydralazine and lactose were used as raw materials, and silica gel column and preparation column of octadecylsilane bonded silica were selected to prepare and purify hydralazine-N-lactose. Its in vitro metabolites were identified by utilizing SD rat liver microsomes. The results of samples in vitro were compared with blank group and the resulting metabolites structures were identified by LC-MS/MS. Hydrazine-N-lactose produced six main metabolites, including s-triazolo[3, 4-a]phthalazine, 3-methyl-s-triazolo[3, 4-a]phthalazine, 3-(1-hydroxy)methyl-s-triazolo[3, 4-a]phthalazine, 3-hydroxymethyl-s-triazolo[3, 4-a]phthalazine, hydralazine and dehydro-hydralazine-N-lactose after in vitro metabolism. This study will be valuable in hydralazine-lactose conjunctions metabolism research and hydralazine formulation safety.
  • [1]
    Moyer JH.Hydrallazine(apresoline)hydrochloride;pharmacological observations and clinical results in the therapy of hypertension[J].AMA Arch Intern Med,1953,91(4):419-439.
    [2]
    Gottlieb TB,Katz FH,Chidsey CA.Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension.A comparative study of minoxidil and hydralazine[J].Circulation,1972,45(3):571-582.
    [3]
    Huang F.A pharmaceutical composition of hydralazine hydrochloride and its pharmaceutical use:CN,105859738A[P].2006-05-19[2017-02-19] .
    [4]
    Taylor AL,Ziesche S,Yancy CW,et al.Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine:consistency across subgroups in the African-American heart failure trial[J].Circulation,2007,115(13):1747-1753.
    [5]
    Ren FX.A compound reserpine tablet for the treatment of hypertension and its preparation method:CN,105213425A[P].[2015-11-03] .
    [6]
    Das Gupta V, Stewart KR, Bethea C. Stability of hydralazine hydrochloride in aqueous vehicles[J].J Clin Hosp Pharm,1986,11(3):215-223.
    [7]
    Lessen T, Zhao DC. Interactions between drug substances and excipients.1.Fluorescence and HPLC studies of triazolophthalazine derivatives from hydralazine hydrochloride and starch[J].J Pharm Sci,1996,85(3):326.
    [8]
    Dong XY,Tao WY,Liu M,et al.Study on the related substances in hydralazine hydrochloride tablets by LC-MS/MS[J].Chin J Pharm Anal(药物分析杂志),2016,36(1):155-161.
    [9]
    Streeter AJ,Timbrell JA.Studies on the in vivo metabolism of hydralazine in the rat[J].Drug Metab Dispos,1983,11(3):184-189.
    [10]
    LaCagnin LB,Colby HD,O′Donnell JP.The oxidative metabolism of hydralazine by rat liver microsomes[J].Drug Metab Dispos,1986,14(14):549-554.
    [11]
    Haegele KD,Skrdlant HB,Robie NW,et al.Determination of hydralazine and its metabolites by gas chromatography-mass spectrometry[J].J Chromatogr,1976,126:517-534.
    [12]
    Timbrell JA,Facchini V,Harland SJ,et al.Hydralazine-induced lupus:is there a toxic metabolic pathway[J]? Eur J Clin Pharmacol,1984,27(5):555-559.

Catalog

    Article views PDF downloads Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return